AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology.
See below for the Latest AstraZeneca News, Analysis, Profit Results, Share Price Information, and Commentary.
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
AstraZeneca’s new cancer drug manufacturing facility to create 800 jobs in Singapore
The facility is set to be operational by 2029.
AstraZeneca plans $2.02b ADC manufacturing facility in Singapore
This is expected to be operational by 2029.
SG acquires AstraZeneca's Evusheld
Evusheld is a long-acting antibody candidate for COVID-19 treatment.
AstraZeneca SG signs MOU with tech partners
The partnerships aim to improve care delivery and patient outcomes.
Read Here
Advertise
Sign Up
Commentary
What Singapore’s app store rules reveal about the future of online trust
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation
From Singapore to Southeast Asia: Thriving in innovation by knowing when to pause
Section 13O, MAS, and the digital footprint of Singapore Family Offices
Could Singapore lead the world's next management revolution?
RIE2030’s real test: Turning innovation into impact
What Singapore logistics operators often overlook when electrifying fleets